Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laetitia Dahan

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Topics in Medicinal Chemistry|September 18, 2012
Targetting esophageal and gastric cancers with monoclonal antibodiesEmmanuelle Norguet, Laetitia Dahan, Jean-Francois Seitz
Oncology (Williston Park, N.Y.)|January 20, 2005
Pemetrexed in pancreatic cancerJean-François Seitz, Laetitia Dahan, Pauline Ries
Nature Reviews. Clinical Oncology|February 10, 2011
Integrating pharmacogenetics into gemcitabine dosing--time for a change?Joseph Ciccolini, Cédric Mercier, Laetitia Dahan, et al.
La Revue Du Praticien|February 26, 2019
[Gastric tumors]Camille Sibertin-Blanc, Laetitia Dahan, Jean-François Seitz
Gastroenterologie Clinique Et Biologique|March 28, 2006
[Palliative endoscopic treatments for esophageal cancers]Laetitia Dahan, Pauline Ries, René Laugier, et al.
Clinical Colorectal Cancer|October 6, 2010
Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?Joseph Ciccolini, Eva Gross, Laetitia Dahan, et al.
European Journal of Clinical Pharmacology|June 22, 2010
Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphismCédric Mercier, Laetitia Dahan, L'houcine Ouafik, et al.
Fundamental & Clinical Pharmacology|July 7, 2025
DPD Ultra-Rapid Metabolizer Status and Efficacy of 5-Fluorouracil Treatment: A Real-World StudyGovind Kallee, Gérard Milano, Florence Duffaud, et al.
Molecular and Cellular Biology|May 20, 2009
NADPH oxidase 1 controls the persistence of directed cell migration by a Rho-dependent switch of alpha2/alpha3 integrinsAmine Sadok, Anne Pierres, Laetitia Dahan, et al.
British Journal of Pharmacology|September 8, 2009
Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell linesLaetitia Dahan, Amine Sadok, Jean-Louis Formento, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Topics in Medicinal Chemistry|September 18, 2012
Targetting esophageal and gastric cancers with monoclonal antibodiesEmmanuelle Norguet, Laetitia Dahan, Jean-Francois Seitz
Oncology (Williston Park, N.Y.)|January 20, 2005
Pemetrexed in pancreatic cancerJean-François Seitz, Laetitia Dahan, Pauline Ries
Nature Reviews. Clinical Oncology|February 10, 2011
Integrating pharmacogenetics into gemcitabine dosing--time for a change?Joseph Ciccolini, Cédric Mercier, Laetitia Dahan, et al.
La Revue Du Praticien|February 26, 2019
[Gastric tumors]Camille Sibertin-Blanc, Laetitia Dahan, Jean-François Seitz
Gastroenterologie Clinique Et Biologique|March 28, 2006
[Palliative endoscopic treatments for esophageal cancers]Laetitia Dahan, Pauline Ries, René Laugier, et al.
Clinical Colorectal Cancer|October 6, 2010
Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?Joseph Ciccolini, Eva Gross, Laetitia Dahan, et al.
European Journal of Clinical Pharmacology|June 22, 2010
Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphismCédric Mercier, Laetitia Dahan, L'houcine Ouafik, et al.
Fundamental & Clinical Pharmacology|July 7, 2025
DPD Ultra-Rapid Metabolizer Status and Efficacy of 5-Fluorouracil Treatment: A Real-World StudyGovind Kallee, Gérard Milano, Florence Duffaud, et al.
Molecular and Cellular Biology|May 20, 2009
NADPH oxidase 1 controls the persistence of directed cell migration by a Rho-dependent switch of alpha2/alpha3 integrinsAmine Sadok, Anne Pierres, Laetitia Dahan, et al.
British Journal of Pharmacology|September 8, 2009
Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell linesLaetitia Dahan, Amine Sadok, Jean-Louis Formento, et al.
Pageof 11